Efficacy and Safety Study of 610 in Patients With Severe Asthma

This study is testing an investigational drug called "610" in adults with severe asthma that is not well controlled with current treatments. The goal is to evaluate whether this new medication can reduce asthma symptoms and improve lung function safely. **You may be eligible if:** - You are between 18 and 75 years old - You have been diagnosed with asthma for at least one year - Your asthma is classified as severe and requires inhaled corticosteroids plus at least one other controller medication - Your asthma has been managed with these medications for at least 6 months **You may NOT be eligible if:** - You have another significant lung condition besides asthma - You had a severe asthma attack (exacerbation) within the 4 weeks before the study starts - You have other eosinophilic conditions (conditions where a type of white blood cell called eosinophils is elevated for a different reason) - You have serious cardiovascular disease - You have other significant concurrent medical conditions Talk to your doctor to see if this trial is right for you.